BPC-157
Pentadecapeptide of gastric origin, studied in tissue-repair models.
1 × $20 = $20. Applied in your cart.
- Every batch tested by an independent laboratory — identity by HPLC and mass spec.
- Dispatched on business days once payment has cleared. Free shipping over $100 — flat $10 otherwise.
- Discreet packaging, tracked and insured on every shipment.
For laboratory and research use only · Not for human consumption
- Certificate
- 99.90% purity · marked out of specification
- Sizes
- 10mg · 20mg
- Molecular weight
- 1419.5 g/mol
- Form
- Lyophilised powder, sealed vial
- Storage
- Cool, dry and out of direct light; refrigerate once reconstituted
Measured, not claimed.
Purity by HPLC
From this lot's own certificate, published exactly as the laboratory issued it.
- Lot
- 1500-501
- Tested
- Jun 27, 2026
- Laboratory
- Pacific Coast Biologics Inc
Measured on this lot
- Appearance
- Lyophilized Powder
- Identity Confirmation
- 31.0% Acetonitrile
- Molecular Formula
- C₆₂H₉₈N₁₆O₂₂
- Molecular Weight
- 1,419.5 Da
Analysed against
- Identity
- HPLC + mass spec
- Purity
- HPLC · figure on the batch COA
- Net peptide content
- HPLC
- Heavy metals
- ICP-MS
- Sterility
- PCR
- Endotoxin
- USP <85>
What it is
BPC-157 is a pentadecapeptide — fifteen amino acids in a single unbranched chain, sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It corresponds to a partial sequence of body protection compound, a protein identified in human gastric juice. The material is made by solid-phase synthesis rather than extracted, so each batch begins from defined reagents rather than from tissue.
It ships lyophilised: a dry white powder in a sealed vial, shipped at ambient temperature and reconstituted in the laboratory with bacteriostatic water. The batch identifier on the vial matches the certificate of analysis held on file for that synthesis run.
What the research explores
BPC-157 appears in the preclinical literature chiefly as a subject of tissue-repair research. The published work is animal- and cell-model based, and the peptide has no approved application in humans.
Areas investigators have examined:
- Tendon, ligament and muscle repair models, including fibroblast migration and outgrowth in culture
- Angiogenesis, with particular attention to VEGFR2 signalling and the nitric oxide system
- Gastrointestinal mucosal integrity models, the context in which the parent sequence was first characterised
- Interaction with growth factor and neurotransmitter pathways in rodent studies
Findings across this body of work are preliminary and unevenly replicated. BPC-157 is supplied strictly as a laboratory research material.
Questions
How should the vial be stored?
As a sealed lyophilised powder it is kept cool, dry and out of direct light. Ambient temperature during transit is normal for lyophilised peptides and is not a problem. Once reconstituted, the vial belongs in a refrigerator.
What does the certificate of analysis cover?
The COA records the analytical results for the specific batch in your vial: identity confirmation, purity by HPLC, and the batch identifier printed on the label. We hold one on file for every synthesis run and will send the PDF on request.
What arrives in the package?
The sealed vial of lyophilised peptide, labelled with its lot number. Nothing is pre-mixed. Bacteriostatic water and reconstitution supplies are listed separately in the catalogue.
Is the 20 mg vial different material from the 10 mg?
No. Both hold the same lyophilised peptide from the same synthesis and testing process, and both carry a batch-matched COA. The only difference is the quantity in the vial.
Which lot is BPC-157's published certificate for?
Lot 1500-501, measured 99.90% by HPLC, tested Jun 27, 2026, by Pacific Coast Biologics Inc. The full certificate, including the laboratory's own assay rows, is published at /coa/SXPR6UCKPL.
Literature
7 publications · 2011–2025
Peer-reviewed publications indexed on PubMed that discuss BPC-157. Listed for reference only — inclusion is not a claim about this product or its effects.
- 2025Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing
McGuire FP, Martinez R, Lenz A, et al. · Current reviews in musculoskeletal medicine
PMID 40789979 · doi 10.1007/s12178-025-09990-7
- 2025Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review
Józwiak M, Bauer M, Kamysz W, et al. · Pharmaceuticals (Basel, Switzerland)
PMID 40005999 · doi 10.3390/ph18020185
- 2022Pentadecapeptide BPC 157 and the central nervous system
Vukojevic J, Milavić M, Perović D, et al. · Neural regeneration research
PMID 34380875 · doi 10.4103/1673-5374.320969
- 2021Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
Seiwerth S, Milavic M, Vukojevic J, et al. · Frontiers in pharmacology
PMID 34267654 · doi 10.3389/fphar.2021.627533
- 2019Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Gwyer D, Wragg NM, Wilson SL · Cell and tissue research
PMID 30915550 · doi 10.1007/s00441-019-03016-8
Show 2 more publicationsShow fewer
- 2018BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing
Seiwerth S, Rucman R, Turkovic B, et al. · Current pharmaceutical design
PMID 29998800 · doi 10.2174/1381612824666180712110447
- 2011The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
Chang CH, Tsai WC, Lin MS, et al. · Journal of applied physiology (Bethesda, Md. : 1985)
PMID 21030672 · doi 10.1152/japplphysiol.00945.2010
Products are supplied strictly for laboratory and research use. They are not for human or veterinary consumption, and have not been evaluated by the U.S. Food and Drug Administration for the diagnosis, treatment, cure, or prevention of any condition.